Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ALW-II-41-27 |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
ALW-II-41-27 is a small molecule that inhibits EPHA2 and RET, leading to decreased tumor cell proliferation and viability (PMID: 24713656, PMID: 26046350, PMID: 32848131). |
| DrugClasses | RET Inhibitor 53 |
| CAS Registry Number | 1186206-79-0 |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| ALW-II-41-27 | ALW-II-41-27 | 4 | 0 |
| ALW-II-41-27 + Cetuximab | ALW-II-41-27 Cetuximab | 0 | 0 |
| ALW-II-41-27 + Paclitaxel | ALW-II-41-27 Paclitaxel | 0 | 0 |